PHASE 3 PROSPECTIVE, RANDOMIZED, BLINDED AND CONTROLLED INVESTIGATION OF HEPASPHERE/QUADRASPHERE MICROSPHERES FOR DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF HEPATOCELLULAR CANCER

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Lopera,Jorge E

Funded by

MERIT MEDICAL SYSTEMS

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Cancer

Bioscience Research Panel